Metraipolis › archive › dc_e43eb1e036cd

Overcoming doramectin failure: field efficacy of pour-on 5% fluralaner and an experimental 1% oral formulation for the prevention of Cochliomyia… — Europe PMC PMID:42310702

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42310702
DOI
10.1186/s13071-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-10-19T09:11:44.991Z
SHA-256 of the archived text
61a7fba9199c10c7117ebc3b09090ede443e14163abef7edf4f3072bba2ad010
Stable URL of this page
https://metraipolis.com/documento/dc_e43eb1e036cd

How to cite

Overcoming doramectin failure: field efficacy of pour-on 5% fluralaner and an experimental 1% oral formulation for the prevention of Cochliomyia… — Europe PMC PMID:42310702 — Europe PMC (en), https://europepmc.org/article/MED/42310702 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e43eb1e036cd (Metraipolis archive dc_e43eb1e036cd, sha256 61a7fba9199c10c7117ebc3b09090ede443e14163abef7edf4f3072bba2ad010)
BibTeX
@misc{dce43eb1e036cd,
  title = {Overcoming doramectin failure: field efficacy of pour-on 5% fluralaner and an experimental 1% oral formulation for the prevention of Cochliomyia… — Europe PMC PMID:42310702},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42310702},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e43eb1e036cd; sha256 61a7fba9199c10c7117ebc3b09090ede443e14163abef7edf4f3072bba2ad010},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42310702. Agents can read the archived copy with the MCP tool read_document.